Abstract
A converting enzyme inhibitor should theoretically block all the actions of angiotensin II and simultaneously enhance those of kinins. It must, therefore, be beneficial when used in pathological situations where the range of these actions has become deranged, as seen in many types of hypertension and in congestive heart failure. Some side effects may also appear if it is used improperly (Figure 1).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
H. Kamei and K. Arakawa, Effect of angiotensin converting enzyme inhibitor on serum aldosterone and potassium level, Jpn Heart ç J., 23: 191–199 (1982).
H. Gavras, A. Benetos and I. Gavras, Contribution of bradykinin to maintenance of normal blood pressure, Hypertension (Suppl. III), 9: 111–147–111–149 (1987).
K. Abe, T. Itoh, Y. Imai, M. Sato, T. Haruyama, Y. Sakurai, T. Goto, Y. Otsuki and K. Yoshinaga, Implication of endogenous prostaglandin system in the antihypertensive effect of Captopril, SQ 14225, in low renin hypertension, Jpn Circ J., 44: 422–425 (1980).
CS-522 Research Group, Antihypertensive effect of Captopril, an angiotensin converting enzyme inhibitor, in mild and moderate essential hypertension-Results of a multiclinic open trial, Jpn Pharmacol. & Ther. 9: 4073–4101 (1981)(in Japanese).
Y. Kaneko, K. Yamada, M. Kaneko, T. Omae, T. Takeda, H. Shionoiri, Z. Masuyama, Y. Kumahara, T. Kokubu and K. Arakawa, Clinical effects of CS-522 (Captopril) monotherapy in essential hypertension,-a double blind study with propranolol, Igakuno yumi, 122: 62–85 (1982)(in Japanese).
CS-522 Study Group, Effect of Captopril, an angiotensin converting enzyme inhibitor, in the patients with severe essential and secondary hypertension-Results of a multiclinic open trial, Jpn Pharmacol. & Ther., 9: 4103–4130 (1981)(in Japanese).
A. J. Merrill, J. L. Morrison and E. S. Brannon, Concentration of renin in renal venous blood in patients with chronic heart failure, Am J. Med., I: 468–472 (1946)
G. S. Francis, Neurohumoral mechanisms involved in congestive heart failure, Am J. Cardiol., 55: 15A–21A (1985).
J. G. F. Cleland, H. J. Dargie, G. P. Hodsman, S. G. Ball, J. I. S. Robertson, J. J. Morton, B. W. East, I. Robertson, G. D. Murray and G. Gillen, A controlled trial of enalapril in cardiac failure, Br Heart J., 54: 305–312 (1985)
10. D. N. Sharpe, R. J. Coxon, J. E. Douglas and B. Long, Low-dose Captopril in chronic heart failure: acute haemodynamic effects and long-term treatment, Lancet, ii: 1154–1157 (1980).
C.D. Furberg and S. Yusuf, Effect of vasodilators on survival in chronic congestive heart failure, Am J. Cardiol., 55: 1110–1113 (1985).
D. P. Faxon, M. A. Creager, J. L. Halperin, H. A. Sussman, H. Gavras and T. J. Ryan, The effect of angiotensin converting enzyme inhibition on coronary blood flow and haemodynamics in patients without coronary artery disease, Int J. Cardiol., 2: 251–262 (1982).
G. Ertl, R. A. Kloner, R. W. Alexander and E. Braunwald, Limitation of experimental infarct size by an angiotensin-converting enzyme inhibitor, Circulation 65: 40–48 (1982).
O. B. Paulson, J. O. Jarden, J. Godtfredsen and S. Vorstrup, Cerebral blood flow in patients with congestive heart failure treated with Captopril, Am J. Med., 76(5B): 91–95 (1984).
M. A. Creager, J. L. Halperin, D. B. Bernard, D. P. Faxon, C. D. Melidossian, H. Gavras and T. J. Ryan, Acute regional circulatory and renal hemodynamic effects of converting-enzyme inhibition in patients with congestive heart failure, Circulation, 64: 483–489 (1981).
J. Sasaki and K. Arakawa, Effect of Captopril on serum lipids, lipoproteins, and apolipoproteins in patients with mild essential hypertension. Curr Ther. Res., 40: 898–902 (1986).
S. H. Croog, S. Levine, M. A. Testa, B. Brown, C. J. Bulpitt, C. D. Jenkins and G. L. Klerman, The effects of antihypertensive therapy on the quality of life, N Engl. J. Med., 314: 1657–1664 (1986).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Press, New York
About this chapter
Cite this chapter
Arakawa, K. (1989). Beneficial and Adverse Effects of Angiotensin Converting Enzyme Inhibitors. In: Abe, K., Moriya, H., Fujii, S. (eds) Kinins V. Advances in Experimental Medicine and Biology, vol 247 A. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-9543-4_10
Download citation
DOI: https://doi.org/10.1007/978-1-4615-9543-4_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-9545-8
Online ISBN: 978-1-4615-9543-4
eBook Packages: Springer Book Archive